These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2741142)

  • 41. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ki67 index and S-phase fraction on fine-needle aspirates from breast carcinomas.
    Naldi N; Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Mazzini G
    Eur J Histochem; 1997; 41 Suppl 2():79-80. PubMed ID: 9859793
    [No Abstract]   [Full Text] [Related]  

  • 43. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors.
    Magdelenat H; Merle S; Zajdela A
    Cancer Res; 1986 Aug; 46(8 Suppl):4265s-4267s. PubMed ID: 3524807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen receptor analysis on fine needle aspirates from human breast carcinoma.
    Silfverswärd C; Wallgren A; Nordenskjöld B; Humla S
    Recent Results Cancer Res; 1984; 91():41-4. PubMed ID: 6729226
    [No Abstract]   [Full Text] [Related]  

  • 46. Measurements of DNA synthesis and estrogen receptor in needle aspirates as powerful methods in the management of mammary carcinoma.
    Nordenskjöld B; Skoog L; Wallgren A; Silfverswärd C; Gustafsson S; Ljung BM; Westerberg H; Gustafsson JA; Wrange O
    Adv Enzyme Regul; 1980; 19():489-96. PubMed ID: 7337034
    [No Abstract]   [Full Text] [Related]  

  • 47. The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.
    Hawkins RA; Sangster K; Tesdale A; Levack PA; Anderson ED; Chetty U; Forrest AP
    Br J Cancer; 1988 Jul; 58(1):77-80. PubMed ID: 3166894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of fine needle aspirates for immunocytochemical studies.
    Heyderman E; Brown BM
    Lancet; 1986 Aug; 2(8505):520-1. PubMed ID: 2875270
    [No Abstract]   [Full Text] [Related]  

  • 49. The ups and downs of the estrogen receptor.
    Jordan VC
    J Clin Oncol; 2003 Jan; 21(1):3-4. PubMed ID: 12506162
    [No Abstract]   [Full Text] [Related]  

  • 50. New biologies and therapies for breast cancer.
    Cantwell BM
    Ir J Med Sci; 1988 Jul; 157(7):221. PubMed ID: 3170147
    [No Abstract]   [Full Text] [Related]  

  • 51. Heterogeneity of estrogen receptor in primary breast carcinoma evaluated by computed image analysis.
    Simony J; Pujol JL; Grenier J; Pujol H
    Am J Clin Pathol; 1989 Oct; 92(4):559. PubMed ID: 2801617
    [No Abstract]   [Full Text] [Related]  

  • 52. Detection of growth hormone-releasing hormone in cytologic specimens of primary breast carcinoma.
    Chatzistamou I; Kondi-Pafiti A; Politi E; Koutselini H; Schally AV
    Acta Cytol; 2005; 49(1):108-9. PubMed ID: 15717766
    [No Abstract]   [Full Text] [Related]  

  • 53. Estrogen receptors and lymphocytic lymphoma.
    Morgan D
    Ann Intern Med; 1981 Dec; 95(6):783. PubMed ID: 6895447
    [No Abstract]   [Full Text] [Related]  

  • 54. Quantitative determination of enzymic activities in cells and in extracellular fluid aspirated from human tumors by needle biopsy.
    VOZELJ M; ZAJICEK J
    Experientia; 1962 Mar; 18():149-50. PubMed ID: 13926881
    [No Abstract]   [Full Text] [Related]  

  • 55. [Determination of estrogen receptors in fine-needle aspirates from breast carcinoma. A description of a method].
    Lilleng R; Hagmar B; Myrtvedt M; Ottestad L
    Tidsskr Nor Laegeforen; 1989 May; 109(15):1630-2. PubMed ID: 2741142
    [No Abstract]   [Full Text] [Related]  

  • 56. [Determination of estrogen receptor status in breast cancer by immunocytochemical examination of fine-needle aspirates].
    Balslev E; Nielsen M; Jensen OJ; Francis D; Thorpe SM
    Ugeskr Laeger; 1992 Nov; 154(48):3395-8. PubMed ID: 1462448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determination of estrogen receptors in aspirates from needle biopsies of breast carcinomas. Correlation to a biochemical method].
    Sauer T; Naess O; Kåresen R; Jacobsen U; Amlie E; Haug E
    Tidsskr Nor Laegeforen; 1994 Apr; 114(9):1053-5. PubMed ID: 8009516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor analysis on needle aspirates from human mammary carcinoma.
    Silfverswärd C; Humla S
    Acta Cytol; 1980; 24(1):54-7. PubMed ID: 6928336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fine-needle aspiration biopsy of a case of breast carcinoma with choriocarcinomatous features.
    Siddiqui NH; Cabay RJ; Salem F
    Diagn Cytopathol; 2006 Oct; 34(10):694-7. PubMed ID: 16955470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Drill biopsy and puncture biopsy for the determination of hormone receptors].
    Magdelenat H
    Pathol Biol (Paris); 1983 Nov; 31(9):755-60. PubMed ID: 6361673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.